Clinton Musil's most recent trade in Crescent Biopharma Inc. was a trade of 54,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 8, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Crescent Biopharma Inc. | Clinton Musil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 54,000 | 54,000 | - | - | Stock Option (Right to Buy) |